| Burden of Ischemic Heart Disease and Its Attributable Risk Factors in North Africa and the Middle East, 1990 to 2019: Results From the GBD Study 2019 A Aminorroaya, S Saeedi Moghaddam, H Tavolinejad, Z Aryan, B Heidari, ... Journal of the American Heart Association 13 (2), e030165, 2024 | | 2024 |
| Impact of Initial Timing of Metastatic Disease on Survival in Patients With Newly Diagnosed Metastatic Castration-Resistant Prostate Cancer Treated With Androgen Receptor … G Gebrael, N Sayegh, N Tripathi, D Goel, T McFarland, H Ebrahimi, ... Urology Practice, 10.1097/UPJ. 0000000000000471, 2023 | 1 | 2023 |
| Unique Spectrum of Activating BRAF Alterations in Prostate Cancer A Chehrazi-Raffle, H Tukachinsky, E Toye, S Sivakumar, AB Schrock, ... Clinical Cancer Research 29 (19), 3948-3957, 2023 | 5 | 2023 |
| Risk of incident cardiovascular diseases at national and subnational levels in Iran from 2000 to 2016 and projection through 2030: Insights from Iran STEPS surveys H Ebrahimi, M Masinaei, A Aminorroaya, Z Aryan, P Mehdipour, ... Plos one 18 (8), e0290006, 2023 | 1 | 2023 |
| Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy DV Castro, SR Prajapati, MI Feng, EH Chan, KO Lee, T Paul, I Sehgal, ... BJU international, 2023 | 1 | 2023 |
| Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell Carcinoma A Chehrazi-Raffle, S Leong, S Ali, T Kim, S Melamed, X Li, Z Zengin, ... The Oncologist, oyad190, 2023 | | 2023 |
| Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer … H Ebrahimi, DV Castro, MI Feng, SR Prajapati, KO Lee, EH Chan, T Paul, ... Clinical Genitourinary Cancer, 2023 | 1 | 2023 |
| Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell Carcinoma ZB Zengin, A Govindarajan, N Salgia, N Sayegh, N Tripathi, R Muddasani, ... European Urology Oncology, 2023 | 2 | 2023 |
| eLife’s new model and its impact on science communication L Urban, M De Niz, F Fernández-Chiappe, H Ebrahimi, LKM Han, ... Elife 11, e84816, 2022 | 3 | 2022 |
| Recommendations for empowering early career researchers to improve research culture and practice BA Kent, C Holman, E Amoako, A Antonietti, JM Azam, H Ballhausen, ... PLoS Biology 20 (7), e3001680, 2022 | 39 | 2022 |
| Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis … JM Kocarnik, K Compton, FE Dean, W Fu, BL Gaw, JD Harvey, ... JAMA oncology 8 (3), 420-444, 2022 | 1094 | 2022 |
| Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global … S Safiri, AA Kolahi, M Naghavi BMJ global health 6 (11), e004128, 2021 | 52 | 2021 |
| Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 H Ebrahimi, Z Aryan, SS Moghaddam, C Bisignano, S Rezaei, F Pishgar, ... The Lancet Respiratory Medicine 9 (9), 1030-1049, 2021 | 122 | 2021 |
| Five insights from the global burden of disease study 2019 CJL Murray, C Abbafati, KM Abbas, M Abbasi, M Abbasi-Kangevari, ... The Lancet 396 (10258), 1135-1159, 2020 | 621 | 2020 |
| Research Communication: Ways to increase equity, diversity and inclusion D Mehta, Y Bediako, CM De Winde, H Ebrahimi, F Fernández-Chiappe, ... Elife 9, e60438, 2020 | 15 | 2020 |
| Point of View: Mitigating the impact of conference and travel cancellations on researchers’ futures T Weissgerber, Y Bediako, CM De Winde, H Ebrahimi, ... Elife 9, e57032, 2020 | 47 | 2020 |
| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to … Global Burden of Disease Cancer Collaboration JAMA oncology 5 (12), 1749-1768, 2019 | 536 | 2019 |
| Global, regional and national burden of testicular cancer, 1990–2016: results from the Global Burden of Disease Study 2016 F Pishgar, A Haj‐Mirzaian, H Ebrahimi, S Saeedi Moghaddam, B Mohajer, ... BJU international 124 (3), 386-394, 2019 | 52 | 2019 |
| Insulin pen use and diabetes treatment goals: A study from Iran STEPS 2016 survey H Ebrahimi, F Pishgar, M Yoosefi, S Moradi, N Rezaei, S Djalalinia, ... PLoS One 14 (8), e0221462, 2019 | 18 | 2019 |
| Global, Regional and National Burden of Bladder Cancer, 1990 to 2016: Results from the GBD Study 2016 H Ebrahimi, E Amini, F Pishgar, SS Moghaddam, B Nabavizadeh, ... The Journal of urology 201 (5), 893-901, 2019 | 85 | 2019 |
